ArticleCureus2020
Secondary Abdominal Cocoon Syndrome Due To Chronic Beta-Blocker Use.
Article in Cureus, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 7 citations in OpenAlex.
- Abdominal Cocoon Syndrome: A Rare Condition That Causes Diagnostic ChallengesThe Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2026Article
- Abdominal cocoon syndrome in a 10-year-old young adolescent after abdominal operation: A case report and review of literature.World journal of clinical cases · 2025Article
- Sclerosing encapsulating peritonitis in advanced liver cirrhosis presenting with acute small bowel obstruction: a case report and literature review.Journal of surgical case reports · 2025Article
- Primary sclerosing encapsulating peritonitis: a case report.Journal of medical case reports · 2023Article
- Abdominal cocoon syndrome, a rare cause of intestinal obstruction presenting in an Asian adult male: a case report.Annals of medicine and surgery (2012) · 2023Article
- Abdominal Cocoon With Intestinal Perforation: A Case Report.Frontiers in surgery · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sclerosing encapsulating peritonitis (SEP), which is interchangeably used with the term ''abdominal cocoon syndrome'', is a rare condition characterized by a thick fibrous membrane encasing portions of the intestinal wall leading to recurrent bowel obstructions. To date, literature describing the association between this condition and chronic beta-blocker therapy is scarce. This report adds by detailing a rare presentation of SEP and highlights an understudied yet important association of SEP with chronic beta-blocker therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.